Plumbagin suppresses epithelial to mesenchymal transition and stemness via inhibiting Nrf2-mediated signaling pathway in human tongue squamous cell carcinoma cells

Plumbagin suppresses epithelial to mesenchymal transition and stemness via inhibiting Nrf2-mediated signaling pathway in human tongue squamous cell carcinoma cells

Shu-Ting Pan,1 Yiru Qin,2 Zhi-Wei Zhou,2,3 Zhi-Xu He,3 Xueji Zhang,4 Tianxin Yang,5 Yin-Xue Yang,6 Dong Wang,7 Shu-Feng Zhou,2 Jia-Xuan Qiu1 1Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, People’s Republic of China;...

Full description

Bibliographic Details
Main Authors:	Pan ST, Qin Y, Zhou ZW, He ZX, Zhang X, Yang T, Yang YX, Wang D, Zhou SF, Qiu JX
Format:	Article
Language:	English
Published:	Dove Medical Press 2015-10-01
Series:	Drug Design, Development and Therapy
Online Access:	https://www.dovepress.com/plumbagin-suppresses-epithelial-to-mesenchymal-transition-and-stemness-peer-reviewed-article-DDDT

Similar Items

Plumbagin induces G2/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell carcinoma cells
by: Pan ST, et al.
Published: (2015-03-01)

Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells
by: Qui JX, et al.
Published: (2015-01-01)

The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells
by: Li JP, et al.
Published: (2015-02-01)

Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells
by: Wang F, et al.
Published: (2015-01-01)

Alisertib, an Aurora kinase A inhibitor, induces apoptosis and autophagy but inhibits epithelial to mesenchymal transition in human epithelial ovarian cancer cells
by: Ding YH, et al.
Published: (2015-01-01)

Plumbagin Regulates Snail to Inhibit Hepatocellular Carcinoma Epithelial-Mesenchymal Transition in vivo and in vitro
by: Du YQ, et al.
Published: (2024-03-01)

Proteomic response to 5,6-dimethylxanthenone 4-acetic acid (DMXAA, vadimezan) in human non-small cell lung cancer A549 cells determined by the stable-isotope labeling by amino acids in cell culture (SILAC) approach
by: Pan ST, et al.
Published: (2015-02-01)

Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells
by: Yuan CX, et al.
Published: (2015-03-01)

Plumbagin suppresses endothelial progenitor cell-related angiogenesis in vitro and in vivo
by: Hsiang-Ping Lee, et al.
Published: (2019-01-01)

Plumbagin protects against hydrogen peroxide-induced neurotoxicity by modulating NF-κB and Nrf-2
by: Wang Kuan-hong, et al.
Published: (2016-12-01)

Estimation of the binding modes with important human cytochrome P450 enzymes, drug interaction potential, pharmacokinetics, and hepatotoxicity of ginger components using molecular docking, computational, and pharmacokinetic modeling studies
by: Qiu JX, et al.
Published: (2015-02-01)

Plumbagin Ameliorates Collagen-Induced Arthritis by Regulating Treg/Th17 Cell Imbalances and Suppressing Osteoclastogenesis
by: Tingyu Wang, et al.
Published: (2019-01-01)

Vimentin is a potential prognostic factor for tongue squamous cell carcinoma among five epithelial-mesenchymal transition-related proteins.
by: Pei-Feng Liu, et al.
Published: (2017-01-01)

Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway
by: Niu NK, et al.
Published: (2015-03-01)

Plumbagin Modulates Leukemia Cell Redox Status
by: François Gaascht, et al.
Published: (2014-07-01)

Epithelial-to-Mesenchymal Transition-Derived Heterogeneity in Head and Neck Squamous Cell Carcinomas
by: Philipp Baumeister, et al.
Published: (2021-10-01)

Transcriptomic dissection of tongue squamous cell carcinoma
by: Schwartz Joel L, et al.
Published: (2008-02-01)

Safflower polysaccharide inhibits the development of tongue squamous cell carcinoma
by: Haiyan Zhou, et al.
Published: (2018-08-01)

Plumbagin inhibits growth of gliomas in vivo via suppression of FOXM1 expression
by: Mingshan Niu, et al.
Published: (2015-07-01)

Suppression of MAGE-A10 alters the metastatic phenotype of tongue squamous cell carcinoma cells
by: Bruna dos Santos Mendonça, et al.
Published: (2017-07-01)

Childhood tongue squamous cell carcinoma
by: Iraj Harirchi, et al.
Published: (2012-01-01)

Epithelial-to-Mesenchymal Transition and Neoangiogenesis in Laryngeal Squamous Cell Carcinoma
by: Leonardo Franz, et al.
Published: (2021-07-01)

The growth inhibitory effect of human gingiva-derived mesenchymal stromal cells expressing interferon-β on tongue squamous cell carcinoma cells and xenograft model
by: Lingqian Du, et al.
Published: (2019-07-01)

Retraction: Plumbagin Ameliorates Collagen-Induced Arthritis by Regulating Treg/Th17 Cell Imbalances and Suppressing Osteoclastogenesis
by: Frontiers Editorial Office
Published: (2020-01-01)

The Crosstalk between Nrf2 and TGF-β1 in the Epithelial-Mesenchymal Transition of Pancreatic Duct Epithelial Cells.
by: Sarah Arfmann-Knübel, et al.
Published: (2015-01-01)

AM251 Suppresses Epithelial-Mesenchymal Transition of Renal Tubular Epithelial Cells.
by: Tomoyo Yoshinaga, et al.
Published: (2016-01-01)

Early invasive squamous cell carcinoma of the tongue
by: Sharad Vaidya, et al.
Published: (2013-01-01)

Plumbagin Elicits Cell-Specific Cytotoxic Effects and Metabolic Responses in Melanoma Cells
by: Haoran Zhang, et al.
Published: (2021-05-01)

Prognostic impact of lymphovascular and perineural invasion in squamous cell carcinoma of the tongue
by: Qiongling Huang, et al.
Published: (2023-03-01)

Carbonic Anhydrase III Promotes Cell Migration and Epithelial–Mesenchymal Transition in Oral Squamous Cell Carcinoma
by: Yin-Hung Chu, et al.
Published: (2020-03-01)

Transgelin Inhibits the Malignant Progression of Esophageal Squamous Cell Carcinomas by Regulating Epithelial–Mesenchymal Transition
by: Boli Yang, et al.
Published: (2021-08-01)

Suppressive effects of plumbagin on the growth of human bladder cancer cells via PI3K/AKT/mTOR signaling pathways and EMT
by: Renjie Zhang, et al.
Published: (2020-10-01)

Controllable drug uptake and nongenomic response through estrogen-anchored cyclodextrin drug complex
by: Yin JJ, et al.
Published: (2015-07-01)

Anticancer Activity of Copolymeric Nanoparticles Loaded by Plumbagin on Breast Cancer cells
by: Hossein Danafar, et al.
Published: (2022-07-01)

Depletion of PHLDB2 Suppresses Epithelial–Mesenchymal Transition and Enhances Anti-Tumor Immunity in Head and Neck Squamous Cell Carcinoma
by: Hongyu Li, et al.
Published: (2024-02-01)

LINC00958 promotes proliferation, migration, invasion, and epithelial-mesenchymal transition of oesophageal squamous cell carcinoma cells.
by: Biqi Wang, et al.
Published: (2021-01-01)

Sulfiredoxin may promote metastasis and invasion of cervical squamous cell carcinoma by epithelial–mesenchymal transition
by: Xiaoyan Chen, et al.
Published: (2017-03-01)

Gremlin1 Delivered by Mesenchymal Stromal Cells Promoted Epithelial-Mesenchymal Transition in Human Esophageal Squamous Cell Carcinoma
by: Dongxi Hong, et al.
Published: (2018-06-01)

Epithelial-mesenchymal transition related to bone invasion in oral squamous cell carcinoma
by: Jaqueline Vaz Vanini, et al.
Published: (2022-04-01)

Inhibitory activities of plumbagin on cell migration and invasion and inducing activity on cholangiocarcinoma cell apoptosis
by: Luxsana Panrit, et al.
Published: (2018-01-01)